by The global kidney stone management market size was valued at USD 2.73 billion in 2023 and is projected to hit around USD 4.65 billion by 2033, growing at a CAGR of 5.47% from 2024 to 2033.
Key Points
- North America dominated the kidney stone management market globally in the previous year of 2023, and it is poised to hold its position during the forecast period.
- Asia Pacific is an expanding market and is projected to hold a significant market share in 2023.
- Based on stone type, the calcium oxalate segment held the largest share in the market in 2023.
- Based on diagnostics, the ultrasound segment held a significant share of the market in 2023.
- Based on treatment, the extracorporeal shock wave lithotripsy- ESWL segment held the largest share in 2023 and dominated the kidney stone management market globally
- Based on end use, the hospitals segment held the largest market share and dominated the market.
- Based on end use, the specialty clinics segment is expected to experience the highest growth rate over the forecast period.
The kidney stone management market refers to the sector dedicated to the diagnosis, treatment, and management of kidney stones, which are small, hard mineral and acid salt deposits that form inside the kidneys. This market encompasses a wide range of products and services, including diagnostic imaging techniques, minimally invasive procedures, medications, and surgical interventions. Kidney stones are a common urological condition, affecting millions of people worldwide, and the market for managing them is driven by the increasing prevalence of kidney stone disease, advancements in medical technology, and growing awareness among healthcare professionals and patients about available treatment options.
Get a Sample: https://www.precedenceresearch.com/sample/3941
Growth Factors
Several factors contribute to the growth of the kidney stone management market. Firstly, the rising incidence of kidney stones globally is a significant driver. Factors such as sedentary lifestyles, unhealthy dietary habits, dehydration, and genetic predisposition contribute to the increasing prevalence of kidney stone disease. Additionally, technological advancements in diagnostic imaging modalities such as ultrasound, CT scans, and MRI have improved the accuracy and efficiency of diagnosing kidney stones, leading to early detection and treatment. Moreover, the development of minimally invasive surgical techniques, such as shock wave lithotripsy (SWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL), has revolutionized the management of kidney stones, offering less invasive alternatives to traditional open surgery.
Region Insights:
The kidney stone management market exhibits regional variations in terms of prevalence, treatment approaches, and healthcare infrastructure. In developed regions such as North America and Europe, where healthcare expenditure is relatively high, advanced diagnostic and treatment options are widely available, contributing to better patient outcomes. Conversely, in developing regions like Asia-Pacific, Latin America, and Africa, limited access to healthcare facilities, inadequate infrastructure, and socioeconomic factors can pose challenges to effective kidney stone management. However, with increasing awareness, improving healthcare infrastructure, and growing adoption of advanced medical technologies, these regions are witnessing a gradual expansion of the kidney stone management market.
Kidney Stone Management Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.47% |
| Global Market Size in 2023 | USD 2.73 Billion |
| Global Market Size by 2033 | USD 4.65 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Type of Stone, By Diagnostics Method, By Treatment, and By End-use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Kidney Stone Management Market Dynamics
Drivers:
Several drivers fuel the growth of the kidney stone management market. One of the key drivers is the growing prevalence of risk factors such as obesity, poor dietary habits, sedentary lifestyles, and metabolic disorders, which increase the likelihood of developing kidney stones. Additionally, advancements in medical technology, such as the development of laser lithotripsy, robotic-assisted surgery, and miniaturized endoscopic instruments, have expanded the treatment options available to patients, driving market growth. Furthermore, increasing healthcare expenditure, improving reimbursement policies, and rising awareness among patients about the importance of early detection and treatment of kidney stones are also significant drivers propelling market expansion.
Opportunities:
The kidney stone management market presents several opportunities for growth and innovation. One such opportunity lies in the development of novel diagnostic techniques and biomarkers for early detection and risk stratification of kidney stone disease. Additionally, there is a growing demand for minimally invasive treatment modalities that offer faster recovery times, reduced postoperative pain, and improved patient outcomes. Moreover, expanding market penetration in emerging economies, increasing collaborations between healthcare providers and medical device manufacturers, and investing in research and development for next-generation treatment modalities represent promising opportunities for market players to capitalize on.
Challenges:
Despite the promising growth prospects, the kidney stone management market faces several challenges. One significant challenge is the high recurrence rate of kidney stones, which necessitates long-term management and follow-up care for patients. Additionally, disparities in access to healthcare, particularly in rural and underserved areas, pose challenges to timely diagnosis and treatment of kidney stone disease. Moreover, the high cost associated with advanced diagnostic imaging techniques and surgical interventions may limit access to care for economically disadvantaged populations. Furthermore, regulatory hurdles, reimbursement complexities, and concerns regarding the safety and efficacy of new treatment modalities present challenges for market players seeking to introduce innovative solutions in the kidney stone management market.
Read Also: Facial Skincare Market Size to Worth USD 169.57 Billion by 2033
Recent Developments
- In June 2022, Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System.
- In June 2022, Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value.
Kidney Stone Management Market Companies
- Cook Medical Inc. (US)
- Boston Scientific Corporation (U.S.)
- Olympus Corp. (Japan)
- C.R. Bard Inc. (U.S.)
- Storz Medical AG (Switzerland)
- Richard Wolf GmbH (Germany)
- Lumenis (Israel)
- EDAP TMS (France)
- DirexGroup (Germany)
- Elmed Electronics & Medical Industry & Trade Inc. (Turkey)
- Medi spec Ltd. (U.S.)
- Convergent Laser Technologies (U.S.)
- E.M.S. Electro Medical Systems S.A. (Switzerland)
- Dornier MedTech GmbH (Germany)
- Stryker Corp. (U.S.)
- Olympus Corp. (Japan)
Segments Covered in the Report
By Type of Stone
- Calcium oxalate
- Calcium phosphate
- Uric acid
- Cysteine
- struvite
By Diagnostics Method
- Abdominal X-Ray
- Computed Tomography
- Ultrasound
- Abdominal MRI
- Intravenous Pyelography
- Others
By Treatment
- Extracorporeal Shock Wave Lithotripsy ESWL
- Ureteroscopy
- Percutaneous Nephrolithotomy PCNL
- Others
By End-use
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Other
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.uswebwire.com/
